Neural Tube Defects Prevention
📧 Sign up to get email alerts when something new happens for Neural Tube Defects Prevention.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-08-09FDA Approved: DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium (Sandoz).
-
FDA approval · 2015-07-28FDA Approved: FOLIC ACID — Original Application (SUNRISE PHARMACEUTICAL, INC.)
FDA approved Sunrise Pharmaceutical, Inc.'s folic acid as an Original Abbreviated New Drug Application (ANDA), making a generic folic acid p…
-
FDA approval · 2012-02-13FDA Approved: DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz's Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium, likely re…
-
FDA approval · 2012-02-13FDA Approved: SAFYRAL — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a supplemental application for SAFYRAL (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium) filed by …